NeoGenomics Inc (NEO)
15.38
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Price to Book Value: 2.174 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.171 |
| November 19, 2024 | 2.171 |
| November 18, 2024 | 2.121 |
| November 15, 2024 | 2.126 |
| November 14, 2024 | 2.232 |
| November 13, 2024 | 2.322 |
| November 12, 2024 | 2.308 |
| November 11, 2024 | 2.311 |
| November 08, 2024 | 2.229 |
| November 07, 2024 | 2.236 |
| November 06, 2024 | 2.185 |
| November 05, 2024 | 2.110 |
| November 04, 2024 | 1.998 |
| November 01, 2024 | 1.979 |
| October 31, 2024 | 1.916 |
| October 30, 2024 | 1.902 |
| October 29, 2024 | 1.906 |
| October 28, 2024 | 1.901 |
| October 25, 2024 | 1.843 |
| October 24, 2024 | 1.840 |
| October 23, 2024 | 1.843 |
| October 22, 2024 | 1.864 |
| October 21, 2024 | 1.851 |
| October 18, 2024 | 1.912 |
| October 17, 2024 | 1.904 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.950 |
| October 15, 2024 | 1.978 |
| October 14, 2024 | 1.947 |
| October 11, 2024 | 1.908 |
| October 10, 2024 | 1.909 |
| October 09, 2024 | 1.833 |
| October 08, 2024 | 1.895 |
| October 07, 2024 | 1.943 |
| October 04, 2024 | 1.966 |
| October 03, 2024 | 1.991 |
| October 02, 2024 | 2.022 |
| October 01, 2024 | 1.947 |
| September 30, 2024 | 2.080 |
| September 27, 2024 | 2.029 |
| September 26, 2024 | 2.049 |
| September 25, 2024 | 2.093 |
| September 24, 2024 | 2.211 |
| September 23, 2024 | 2.211 |
| September 20, 2024 | 2.278 |
| September 19, 2024 | 2.306 |
| September 18, 2024 | 2.261 |
| September 17, 2024 | 2.279 |
| September 16, 2024 | 2.285 |
| September 13, 2024 | 2.295 |
| September 12, 2024 | 2.267 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8059
Minimum
Oct 21 2022
10.07
Maximum
Feb 12 2021
3.688
Average
2.316
Median
Price to Book Value Benchmarks
| Bruker Corp | 4.718 |
| Henry Schein Inc | 2.626 |
| Karyopharm Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 14.55 |
| Beam Therapeutics Inc | 2.469 |
Price to Book Value Related Metrics
| PS Ratio | 3.018 |
| Price | 15.38 |
| Earnings Yield | -3.96% |
| Market Cap | 1.975B |